Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcesspositive regulation of microtubule nucleation

MECP2 PDE4DIP

7.78e-058352GO:0090063
GeneOntologyBiologicalProcessinorganic ion import across plasma membrane

CACNA1D SLC9A5 SLC39A10 SLC31A1

9.55e-05142354GO:0099587
GeneOntologyBiologicalProcessinorganic cation import across plasma membrane

CACNA1D SLC9A5 SLC39A10 SLC31A1

9.55e-05142354GO:0098659
GeneOntologyCellularComponentleading edge membrane

CD44 CDKL5 CACNA1D ARHGEF4 SLC9A5

2.48e-05210355GO:0031256
GeneOntologyCellularComponentkeratohyalin granule

FLG FLG2

2.71e-055352GO:0036457
GeneOntologyCellularComponentcell leading edge

CD44 CDKL5 CACNA1D FAT1 ARHGEF4 SLC9A5

1.64e-04500356GO:0031252
GeneOntologyCellularComponentcell projection membrane

CD44 CDKL5 CACNA1D ARHGEF4 SLC9A5

7.10e-04431355GO:0031253
GeneOntologyCellularComponentapical plasma membrane

CD44 CACNA1D FAT1 SLC39A10 SLC31A1

1.23e-03487355GO:0016324
HumanPhenoColdness

CDKL5 MECP2

3.47e-062102HP:0033850
HumanPhenoHand apraxia

CDKL5 MECP2

5.18e-056102HP:0032588
HumanPhenoPill-rolling tremor

CDKL5 MECP2

9.65e-058102HP:0025387
HumanPhenoTotal ophthalmoplegia

CDKL5 MECP2

9.65e-058102HP:0007824
HumanPhenoNeonatal seizure

CDKL5 MECP2

1.89e-0411102HP:0032807
DomainFilaggrin

FLG FLG2

3.22e-062342IPR003303
DomainS100_CABP

FLG FLG2

1.10e-0327342PS00303
DomainS_100

FLG FLG2

1.10e-0327342PF01023
DomainS100_Ca-bd_sub

FLG FLG2

1.18e-0328342IPR013787
DomainS100/CaBP-9k_CS

FLG FLG2

1.18e-0328342IPR001751
DomainS_100

FLG FLG2

1.18e-0328342SM01394
DomainLAM_G_DOMAIN

FAT1 NRXN3

2.17e-0338342PS50025
DomainLaminin_G_2

FAT1 NRXN3

2.40e-0340342PF02210
DomainLamG

FAT1 NRXN3

2.90e-0344342SM00282
DomainLaminin_G

FAT1 NRXN3

4.99e-0358342IPR001791
Domain-

FAT1 NRXN3

1.29e-02953422.60.120.200
Pubmed

MECP2 and CDKL5 gene mutation analysis in Chinese patients with Rett syndrome.

CDKL5 MECP2

9.84e-07235217089071
Pubmed

CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome.

CDKL5 MECP2

9.84e-07235215917271
Pubmed

Convergent cerebrospinal fluid proteomes and metabolic ontologies in humans and animal models of Rett syndrome.

CDKL5 MECP2

9.84e-07235236060065
Pubmed

Rett syndrome: clinical review and genetic update.

CDKL5 MECP2

9.84e-07235215635068
Pubmed

Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation.

CDKL5 MECP2

9.84e-07235215492925
Pubmed

[Methyl-CpG-binding protein 2 gene and CDKL5 gene mutation in patients with Rett syndrome: analysis of 177 Chinese pediatric patients].

CDKL5 MECP2

9.84e-07235219552836
Pubmed

Unusual double mutation in MECP2 and CDKL5 genes in Rett-like syndrome: Correlation with phenotype and genes expression.

CDKL5 MECP2

9.84e-07235232445745
Pubmed

Expression of filaggrin-2 protein in the epidermis of human skin diseases: a comparative analysis with filaggrin.

FLG FLG2

9.84e-07235224813994
Pubmed

[Molecular basis of Rett syndrome: A current look].

CDKL5 MECP2

2.95e-06335226239053
Pubmed

Epilepsy in Rett syndrome: clinical and genetic features.

CDKL5 MECP2

2.95e-06335220728410
Pubmed

Enrichment of mutations in chromatin regulators in people with Rett syndrome lacking mutations in MECP2.

CDKL5 MECP2

2.95e-06335227171548
Pubmed

In Silico Study of Rett Syndrome Treatment-Related Genes, MECP2, CDKL5, and FOXG1, by Evolutionary Classification and Disordered Region Assessment.

CDKL5 MECP2

2.95e-06335231717404
Pubmed

Phenotypes in adult patients with Rett syndrome: results of a 13-year experience and insights into healthcare transition.

CDKL5 MECP2

2.95e-06335233106377
Pubmed

Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin.

FLG FLG2

2.95e-06335223403047
Pubmed

Epilepsy and genetic in Rett syndrome: A review.

CDKL5 MECP2

2.95e-06335230929312
Pubmed

GATA3 regulates FLG and FLG2 expression in human primary keratinocytes.

FLG FLG2

2.95e-06335228928464
Pubmed

Filaggrin and filaggrin 2 processing are linked together through skin aspartic acid protease activation.

FLG FLG2

2.95e-06335232437351
Pubmed

Rett Syndrome, a Neurodevelopmental Disorder, Whole-Transcriptome, and Mitochondrial Genome Multiomics Analyses Identify Novel Variations and Disease Pathways.

CDKL5 MECP2

2.95e-06335232105570
Pubmed

[Clinical features in Rett syndrome: MECP2-, CDKL5- and FOXG1- related disorders].

CDKL5 MECP2

2.95e-06335224738188
Pubmed

The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function.

CACNA1D NRXN3 HUWE1

4.99e-063335322357600
Pubmed

Huwe1-mediated ubiquitylation of dishevelled defines a negative feedback loop in the Wnt signaling pathway.

DVL3 HUWE1

5.90e-06435224643799
Pubmed

CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail.

CDKL5 MECP2

5.90e-06435218701457
Pubmed

Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44.

CD44 SLC16A4

9.82e-06535220454640
Pubmed

Hyaluronan, CD44, and emmprin regulate lactate efflux and membrane localization of monocarboxylate transporters in human breast carcinoma cells.

CD44 SLC16A4

9.82e-06535219176383
Pubmed

Expression of Cornified Envelope Proteins in Skin and Its Relationship with Atopic Dermatitis Phenotype.

FLG FLG2

1.47e-05635227304082
Pubmed

The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.

CD44 CDKL5 FAT1 SLC39A10 RAB11FIP1 TMEM94

2.03e-0556935630639242
Pubmed

Unusual chromatin status and organization of the inactive X chromosome in murine trophoblast giant cells.

HUWE1 MECP2

2.06e-05735223362347
Pubmed

SUMO-specific protease 1 is critical for early lymphoid development through regulation of STAT5 activation.

JAK3 SENP1

4.40e-051035222284677
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

ARHGEF4 SLC39A10 SIPA1L2 TMEM94 PDE4DIP

5.21e-0540735512693553
Pubmed

The protein interaction landscape of the human CMGC kinase group.

DHX15 CDKL5 CCNT2 HUWE1 SIPA1L2 TMEM94

6.17e-0569535623602568
Pubmed

A genome-wide association study on obesity and obesity-related traits.

FAT1 NRXN3

1.02e-041535221552555
Pubmed

SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by Interacting with G3BPs to Facilitate Viral Replication.

FLG SENP1 FLG2 DCAF10

1.06e-0424535435652658
Pubmed

PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.

CD44 DHX15 FLG HUWE1 FLG2

1.10e-0447735531300519
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

CD44 CDKL5 FAT1 HUWE1 SLC39A10 FLG2

1.14e-0477735635844135
Pubmed

Phosphodiesterase 2A2 regulates mitochondria clearance through Parkin-dependent mitophagy.

PRUNE2 HUWE1 SLC31A1

1.68e-0410635333087821
Pubmed

Large-Scale Functional Assessment of Genes Involved in Rare Diseases with Intellectual Disabilities Unravels Unique Developmental and Behaviour Profiles in Mouse Models.

CDKL5 MECP2

1.85e-042035236551904
Pubmed

Variation in genes of the epidermal differentiation complex in German atopic dermatitis patients.

FLG FLG2

2.04e-042135219601998
Pubmed

Cell Surface Proteomic Map of HIV Infection Reveals Antagonism of Amino Acid Metabolism by Vpu and Nef.

CD44 NRXN3 SLC39A10

3.20e-0413235326439863
Pubmed

Arf GTPase-activating protein ASAP1 interacts with Rab11 effector FIP3 and regulates pericentrosomal localization of transferrin receptor-positive recycling endosome.

RAB11FIP1 PDE4DIP

3.40e-042735218685082
Pubmed

LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells.

DHX15 FLG FAT1 HUWE1 SIPA1L2

4.24e-0463935523443559
Pubmed

Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.

DHX15 CDKL5 TMEM131 LEO1

4.64e-0436135430344098
Pubmed

Gene-smoking interactions identify several novel blood pressure loci in the Framingham Heart Study.

NRXN3 SIPA1L2

4.79e-043235225189868
Pubmed

TRIM21 ameliorates hepatic glucose and lipid metabolic disorders in type 2 diabetes mellitus by ubiquitination of PEPCK1 and FASN.

CD44 FLG FLG2 PDE4DIP

5.73e-0438235437249651
Pubmed

Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes?

DHX15 FAT1 HUWE1

6.69e-0417035323314748
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

DHX15 FLG CCNT2 FLG2 SIPA1L2 MECP2

6.70e-04108235638697112
Pubmed

Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy.

JAK3 FAT1 FLG2 TMEM94

6.87e-0440135425852190
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

JAK3 FAT1 ARHGEF4 HUWE1 SIPA1L2 TMEM94

7.48e-04110535635748872
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

SENP1 FAT1 RAB11FIP1 SIPA1L2 INO80D MECP2

7.88e-04111635631753913
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

SLC39A10 RAB11FIP1 SIPA1L2 TMEM94

8.24e-0442135436976175
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

DVL3 CDKL5 OSBP HUWE1 SIPA1L2 PDE4DIP

8.76e-04113935636417873
Pubmed

Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS.

CCNT2 FLG2 TMEM94 PDE4DIP

9.06e-0443235423455922
Pubmed

Defects During Mecp2 Null Embryonic Cortex Development Precede the Onset of Overt Neurological Symptoms.

CACNA1D MECP2

9.48e-044535225979088
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

CCNT2 OSBP HUWE1 LEO1 MECP2

1.01e-0377435515302935
CytobandEnsembl 112 genes in cytogenetic band chr1q21

FLG FLG2 CIART PDE4DIP

2.49e-04404354chr1q21
GeneFamilyEF-hand domain containing|S100 fused type protein family

FLG FLG2

3.84e-0572521350
GeneFamilySolute carriers

SLC9A5 SLC39A10 SLC16A4 SLC31A1

1.97e-03395254752
GeneFamilyPDZ domain containing

DVL3 SIPA1L2

1.86e-021522521220
CoexpressionENK_UV_RESPONSE_KERATINOCYTE_DN

CD44 DHX15 FAT1 ARHGEF4 SLC31A1 MECP2

3.22e-05481346M3898
CoexpressionGSE37301_PRO_BCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP

CDKL5 ZNF394 SIPA1L2 MECP2

3.76e-05146344M8904
ToppCellfacs-Liver-Non-hepatocytes-24m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD44 RAB11FIP1 SIPA1L2 ABCA13

7.07e-06163344abec4389cd88252449f110fe95416d67424b403a
ToppCellfacs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CACNA1D OSBP TMEM94 PDE4DIP

9.15e-06174344f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCellIPF-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class

CD44 FAT1 NRXN3 SIPA1L2

1.46e-051963448f0f72ead06abe02b575e443552eacc2151077ef
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CD44 PRUNE2 CACNA1D FAT1

1.49e-051973447e93a97b5ac5ae2f77a4b3141082a1463fed00dd
ToppCellAT1-AT2_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id

ARHGEF4 NRXN3 CIART

1.82e-04145343cd5de30fd948024e3ad043c9411ce9f2722178b2
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FAT1 SIPA1L2 CCDC85A

2.26e-04156343abf9dd075b1ca8f613c660cc82f8a5af071fb6ab
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FAT1 SIPA1L2 CCDC85A

2.26e-04156343dd41ed918b07fa248da458a629b3c53cb7ea8764
ToppCellLPS-IL1RA-Unknown-Endothelial-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SENP1 PRR14L CIART

2.57e-041633436b11a3ada8725670d0489f404c8c2175ad3904e9
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 FAT1 ABCA13

2.62e-04164343382e42701779d12a7948690b3be72d06dd75c8b4
ToppCellCOVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type

PRUNE2 SIPA1L2 CCDC85A

3.01e-0417234336a96714a0eb6ac438648135336c9791881ddadb
ToppCellPND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SLC9A5 CIART CCDC85A

3.06e-0417334312f779b8dce79431b2d1002ba524dd3f9566aeb0
ToppCellwk_08-11-Mesenchymal-Fibroblast-Airway_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

JAK3 CCDC85A PDE4DIP

3.06e-04173343b23b408acc29a667cce104429afef1a6cf2720a5
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 FAT1 ABCA13

3.22e-04176343327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CD44 NRXN3 SIPA1L2

3.33e-04178343a0ab20c588e7d43d0320d4779d9ab95c1c86e297
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 FAT1 ABCA13

3.38e-0417934358ae5a97fe2a14e1c6fdeb886397eb06fdaf0428
ToppCell3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CD44 PRUNE2 NRXN3

3.38e-04179343e860dca9b28ac5af61804bfd729cd39257cdb352
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

ARHGEF4 RAB11FIP1 CCDC85A

3.38e-041793434f6ca313b78aa93557937a046c44dcf8bcc9963c
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD44 PRUNE2 NRXN3

3.44e-041803436ac62bf1251978c8c12e715f7b73144fca619794
ToppCellAT1_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id

CDKL5 RAB11FIP1 CCDC85A

3.44e-04180343ff4728782c3ec814ba071cc22b7894abdd9da837
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 FAT1 ABCA13

3.50e-041813436956ecd6264f7469a25e555673bce4eb97d28f7a
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FAT1 SIPA1L2 CCDC85A

3.50e-041813435f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FAT1 SIPA1L2 CCDC85A

3.50e-04181343c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 FAT1 ABCA13

3.55e-041823435e1b316599436740f1b30875f0ebd33c3edfb2b6
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 FAT1 ABCA13

3.61e-04183343738e94b50c4c08c727d4eed0708dda08aa6891b4
ToppCellCOVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations)

ARHGEF4 RAB11FIP1 CCDC85A

3.61e-04183343dc1d380bf7564f290256cb7108063d1bd2da732b
ToppCellCOVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type

PRUNE2 FAT1 ABCA13

3.61e-041833436878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 FAT1 ABCA13

3.61e-0418334392fbd83a9d13ee91065cbd479fb298f1fd564568
ToppCellCOVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type

PRUNE2 FAT1 ABCA13

3.67e-0418434351ed1ebfdef45149541917c66cbacad87072e51f
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FAT1 SIPA1L2 CCDC85A

3.73e-0418534334fcfd635c828dad9643bbf1c908d79282d6f5d9
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FAT1 SIPA1L2 CCDC85A

3.73e-041853438816f2909ed11833ff3d0ed96b9cb6d6fe9e1578
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 FAT1 ABCA13

3.79e-041863435c4ffe4e4d5536ae9f8794277fe032c693e7dd56
ToppCellCOVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type

PRUNE2 FAT1 SLC16A4

3.85e-04187343d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf
ToppCellAT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

ARHGEF4 RAB11FIP1 CCDC85A

3.85e-04187343f1dda349335e08dbfc8395d373924037f5ad2fd6
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

TMEM131 HUWE1 INO80D

3.91e-04188343ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FAT1 SIPA1L2 CCDC85A

3.91e-04188343874404a4fd9aa42873f6c53dc42da22d3b0fdb9e
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FAT1 SIPA1L2 CCDC85A

3.91e-04188343b21e93a70583c30d05c0833cd3d4d4bca44a039e
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor

CACNA1D NRXN3 ABCA13

3.91e-04188343ec38def1fdbb34ed9b30244806975bd5a4370164
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 FAT1 SLC16A4

3.97e-0418934328b502611829e4a24caff2562545c7db97686099
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 FAT1 ABCA13

3.97e-04189343904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCellfacs-Brain_Non-Myeloid-Cortex-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC39A10 RAB11FIP1 SLC16A4

4.15e-041923439ae05db5bfb8b9d3935c0328e6f2d489d2b1ebfd
ToppCellAdult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor

CD44 SIPA1L2 PDE4DIP

4.15e-04192343733491e932350e3c216a626cc49c3cd3fe970a82
ToppCellfacs-Brain_Non-Myeloid-Cortex-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC39A10 RAB11FIP1 SLC16A4

4.15e-04192343a116db7dec495e5a0ba9c7537057cd1e567d7885
ToppCellfacs-Brain_Non-Myeloid-Cortex-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC39A10 RAB11FIP1 SLC16A4

4.15e-0419234366defad13bd8e79319741e43ddb056841710b1d7
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 CACNA1D FAT1

4.22e-041933433866667dd221612589ae50f5c52f73a183a49ce6
ToppCell3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CD44 PRUNE2 NRXN3

4.22e-04193343b1893193766ae41bf2ab6ed4083285c9c814e608
ToppCell3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CD44 PRUNE2 NRXN3

4.22e-04193343a402e736440684ebe123673b6b0c6fcd8fa057b2
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 FAT1 ABCA13

4.22e-04193343ffa1932da2979d7b63dbac32eb5788346a3f5b2a
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FAT1 RAB11FIP1 SLC16A4

4.28e-041943434579b4a44f7c731553a284843c296866027d7c0e
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 FAT1 ABCA13

4.28e-041943438ddcaaf24cee6e30d5be52c0cbf778cfba309c53
ToppCell3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CD44 PRUNE2 NRXN3

4.28e-0419434393bc72a933ccc6a760e5353f072afb606571c6fc
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FLG FAT1 SIPA1L2

4.28e-041943431374600957c7d7f0b05fd2c1186f521b9096d4ef
ToppCell3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CD44 PRUNE2 NRXN3

4.35e-0419534326a3a5daf389606ef1ebb35533f12e60853b3a12
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FLG FAT1 SIPA1L2

4.41e-0419634334e79918a448f6c19b87e1b1ce13c012b24be1f8
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FLG FAT1 SIPA1L2

4.41e-041963433cb74f1a333a82cac2b459f2f1517e2acf22b5fd
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FLG FAT1 SIPA1L2

4.41e-041963438f82e01ca50aa4cd6149547505b4474a02fad618
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FLG FAT1 SIPA1L2

4.41e-04196343023477a499a2c190f363cfdbc9d9c646733a6541
ToppCellcontrol-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CD44 JAK3 RAB11FIP1

4.48e-04197343df2fe36cb96e2565a9d21c24cb4e451e8befd4be
ToppCellBronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FAT1 ARHGEF4 ABCA13

4.48e-041973431e915957ea6a4550ecb9d6ee4b232aa5800faf20
ToppCellCOPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class

CD44 NRXN3 SIPA1L2

4.48e-0419734330dbc05ea66892d2e18ff375ffa86d1db7bc4083
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CD44 ZNF394 RAB11FIP1

4.48e-041973434a6eff66a17c5e89bda61d887b736f5c62b93bd7
ToppCell3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CD44 PRUNE2 NRXN3

4.48e-04197343ba6393671a980a1d439307601d18db70a1b1e1f3
ToppCell5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CD44 PRUNE2 NRXN3

4.48e-04197343f4f686d20821af3e6f859b96edc31827a430e3de
ToppCellfacs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD44 DHX15 HUWE1

4.54e-041983432f03f8897dd7cce6d8296638e14e11ec16bcf624
ToppCellfacs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD44 DHX15 HUWE1

4.54e-04198343f2a4057f038ef7225a5b98a7ab068c30dff4eadd
ToppCellfacs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD44 DHX15 HUWE1

4.61e-041993438d50e1ee58710d896c0204937331d9f4dcd38de0
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FLG FAT1 SIPA1L2

4.61e-04199343c972d3036151403f26fa9d6271520639c281ab84
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FLG FAT1 SIPA1L2

4.61e-04199343b9338b739162cd8e5661c9a4dcb41a31219b5723
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 FAT1 SLC16A4

4.68e-04200343105564ee05bd11685b5747ee32d5350cf3c2e2e1
ToppCellBronchial-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FAT1 ARHGEF4 ABCA13

4.68e-042003438827653738a931e4a4545e0c7d75be12bed40740
ToppCellLPS_IL1RA|World / Treatment groups by lineage, cell group, cell type

CD44 SIPA1L2 CCDC85A

4.68e-04200343a02fa5b3c4723a6eaa3c685588666c710478dd25
ToppCellFetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type.

NRXN3 MECP2 PDE4DIP

4.68e-04200343c6bbd33bca86ac7a76a7ba704b3e141237d04549
DrugTremorine dihydrochloride [300-68-5]; Up 200; 15uM; MCF7; HT_HG-U133A

DVL3 JAK3 CACNA1D ARHGEF4 MECP2 PDE4DIP

4.15e-071963466273_UP
Drug5-aza-2′-deoxycytidine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA

CACNA1D CCNT2 PRR14L ARHGEF4 SLC16A4

9.95e-06195345920_UP
DrugFlorfenicol [73231-34-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A

CD44 CACNA1D SLC9A5 MECP2 PDE4DIP

1.05e-051973455300_UP
DrugBenzathine benzylpenicillin [5928-84-7]; Down 200; 4.2uM; MCF7; HT_HG-U133A

CD44 PRUNE2 CACNA1D PRR14L PDE4DIP

1.10e-051993454140_DN
DrugAlexidine dihydrochloride [22573-93-9]; Up 200; 6.8uM; MCF7; HT_HG-U133A

CD44 NRXN3 HUWE1 SLC16A4

1.42e-041793444721_UP
Drug0297417-0002B [362658-29-5]; Up 200; 10uM; MCF7; HT_HG-U133A

CD44 INO80D MECP2 PDE4DIP

1.65e-041863446900_UP
DrugNitrofural [59-87-0]; Down 200; 20.2uM; HL60; HT_HG-U133A

PRR14L INO80D MECP2 PDE4DIP

1.90e-041933442459_DN
Drug(d,l)-Tetrahydroberberine [522-97-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A

DVL3 PRUNE2 JAK3 SLC16A4

1.90e-041933444138_DN
DrugBetahistine mesylate [54856-23-4]; Down 200; 17.2uM; HL60; HT_HG-U133A

CCNT2 INO80D MECP2 TMEM94

1.94e-041943442472_DN
DrugMethylergometrine maleate [113-42-8]; Up 200; 8.8uM; MCF7; HT_HG-U133A

CD44 JAK3 CACNA1D PDE4DIP

1.94e-041943445303_UP
Drug(S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; MCF7; HT_HG-U133A

CACNA1D INO80D MECP2 PDE4DIP

1.98e-041953445325_UP
DrugHydralazine hydrochloride [304-20-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A

CD44 JAK3 NRXN3 INO80D

1.98e-041953444746_UP
DrugNystatine [1400-61-9]; Up 200; 4.4uM; HL60; HT_HG-U133A

JAK3 CCNT2 SLC16A4 PDE4DIP

1.98e-041953442500_UP
DrugDyclonine hydrochloride [536-43-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A

CCNT2 ARHGEF4 INO80D PDE4DIP

1.98e-041953447022_UP
DrugLY 294002; Up 200; 10uM; HL60; HT_HG-U133A

SLC9A5 RAB11FIP1 TMEM94 PDE4DIP

2.02e-041963441168_UP
DrugCefixime [79350-37-1]; Up 200; 8.8uM; PC3; HT_HG-U133A

PRUNE2 CACNA1D SLC16A4 MECP2

2.02e-041963444567_UP
DrugDicloxacillin sodium salt [13412-64-1]; Down 200; 8.2uM; PC3; HT_HG-U133A

ARHGEF4 NRXN3 MECP2 PDE4DIP

2.02e-041963446666_DN
DrugMetoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; PC3; HT_HG-U133A

JAK3 ARHGEF4 NRXN3 PDE4DIP

2.02e-041963444508_UP
DrugSotalol hydrochloride [959-24-0]; Down 200; 13uM; MCF7; HT_HG-U133A

DVL3 CACNA1D CCNT2 SLC9A5

2.06e-041973444160_DN
DrugAconitine [302-27-2]; Down 200; 6.2uM; MCF7; HT_HG-U133A

CD44 CACNA1D PRR14L PDE4DIP

2.06e-041973446797_DN
DrugProbucol [23288-49-5]; Down 200; 7.8uM; PC3; HT_HG-U133A

CCNT2 PRR14L MECP2 PDE4DIP

2.06e-041973444666_DN
DrugDiloxanide furoate [3736-81-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A

DVL3 CACNA1D INO80D PDE4DIP

2.06e-041973445025_DN
DrugIsoxicam [34552-84-6]; Down 200; 12uM; MCF7; HT_HG-U133A

CACNA1D ZNF394 DCAF10 TMEM94

2.06e-041973441698_DN
DrugDeoxycorticosterone [64-85-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A

DVL3 CCNT2 MECP2 PDE4DIP

2.06e-041973445357_UP
DrugStreptozotocin [18883-66-4]; Down 200; 15uM; HL60; HT_HG-U133A

PRUNE2 ARHGEF4 INO80D PDE4DIP

2.10e-041983442535_DN
DrugNaloxone hydrochloride [357-08-4]; Down 200; 11uM; MCF7; HT_HG-U133A

DVL3 ARHGEF4 MECP2 PDE4DIP

2.10e-041983441506_DN
DrugLithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A

CCNT2 NRXN3 MECP2 PDE4DIP

2.10e-041983444551_DN
DrugAmitryptiline hydrochloride [549-18-8]; Up 200; 12.8uM; MCF7; HT_HG-U133A

PRUNE2 CACNA1D ARHGEF4 INO80D

2.10e-041983445453_UP
DrugBupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A

CD44 OSBP MECP2 PDE4DIP

2.10e-041983446256_DN
DrugTetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A

ARHGEF4 ZNF394 MECP2 PDE4DIP

2.10e-041983442080_DN
DrugKetoconazole [65277-42-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A

CD44 JAK3 ARHGEF4 TMEM94

2.10e-041983442640_DN
DrugHydrochlorothiazide [58-93-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A

CACNA1D ARHGEF4 MECP2 PDE4DIP

2.10e-041983444970_DN
DrugOleandomycin phosphate [7060-74-4]; Up 200; 5uM; PC3; HT_HG-U133A

PRUNE2 HUWE1 SLC16A4 PDE4DIP

2.10e-041983444615_UP
DrugTheophylline monohydrate [5967-84-0]; Up 200; 20.2uM; MCF7; HT_HG-U133A

DVL3 SLC9A5 HUWE1 INO80D

2.10e-041983443326_UP
DrugBromopride [4093-35-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A

CD44 CACNA1D INO80D PDE4DIP

2.10e-041983446037_DN
DrugCarbetapentane citrate [23142-01-0]; Down 200; 7.6uM; MCF7; HT_HG-U133A

CD44 CCNT2 INO80D MECP2

2.10e-041983442623_DN
DrugIoversol [87771-40-2]; Up 200; 5uM; MCF7; HT_HG-U133A

CCNT2 ARHGEF4 INO80D PDE4DIP

2.10e-041983445326_UP
DrugHydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; PC3; HT_HG-U133A

CACNA1D NRXN3 HUWE1 PDE4DIP

2.10e-041983445075_UP
DrugNilutamide [63612-50-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A

CD44 SLC9A5 INO80D PDE4DIP

2.10e-041983446481_DN
DrugSulfanilamide [63-74-1]; Down 200; 23.2uM; MCF7; HT_HG-U133A

DVL3 PRR14L SLC9A5 PDE4DIP

2.14e-041993446810_DN
DrugDihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; MCF7; HT_HG-U133A

CACNA1D ARHGEF4 SLC9A5 INO80D

2.14e-041993446840_DN
DrugMethocarbamol [532-03-6]; Up 200; 16.6uM; MCF7; HT_HG-U133A

CD44 DVL3 PRR14L INO80D

2.14e-041993447467_UP
DrugIsoconazole [27523-40-6]; Up 200; 9.6uM; PC3; HT_HG-U133A

ARHGEF4 NRXN3 INO80D PDE4DIP

2.14e-041993445857_UP
DrugMethapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A

DVL3 CACNA1D ARHGEF4 HUWE1

2.14e-041993443205_UP
DrugBumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A

CACNA1D CCNT2 TMEM94 PDE4DIP

2.14e-041993445542_DN
DrugVerapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; MCF7; HT_HG-U133A

DVL3 INO80D MECP2 PDE4DIP

2.14e-041993441509_DN
DrugDiflorasone Diacetate [33564-31-7]; Down 200; 8uM; PC3; HT_HG-U133A

ARHGEF4 NRXN3 INO80D PDE4DIP

2.18e-042003444077_DN
DrugS-(+)-ibuprofen [51146-56-6]; Up 200; 19.4uM; MCF7; HT_HG-U133A

CD44 ARHGEF4 TMEM94 PDE4DIP

2.18e-042003445311_UP
DiseaseRett syndrome (is_implicated_in)

CDKL5 MECP2

1.37e-062352DOID:1206 (is_implicated_in)
DiseaseAngelman Syndrome

CDKL5 MECP2

8.19e-064352C0162635
DiseaseRett Syndrome

CDKL5 MECP2

1.36e-055352C0035372
Diseasegastric adenocarcinoma (is_implicated_in)

CD44 ABCA13

7.47e-0511352DOID:3717 (is_implicated_in)
Diseasegait measurement

CCNT2 NRXN3 CCDC85A

7.48e-04150353EFO_0007680
Diseasepack-years measurement, systolic blood pressure

NRXN3 SIPA1L2

7.49e-0434352EFO_0006335, EFO_0006526
Diseasereticulocyte count

TMEM131 SENP1 FAT1 SLC9A5 DCAF10 INO80D

1.31e-031045356EFO_0007986
Diseaseobesity

FAT1 NRXN3 INO80D

2.90e-03241353EFO_0001073
Diseasedehydroepiandrosterone sulphate measurement

ZNF394 ABCA13

2.96e-0368352EFO_0007001
DiseaseContact hypersensitivity

CD44 FLG

3.23e-0371352C0162351
DiseaseContact Dermatitis

CD44 FLG

3.23e-0371352C0011616

Protein segments in the cluster

PeptideGeneStartEntry
RHHSPSEKSHHSPSE

C2orf16

1781

Q68DN1
SEKSHHSPSERSHHS

C2orf16

1786

Q68DN1
SSHKHSHSHSGSSSG

CCNT2

571

O60583
DDLHSSSHHYSHPGG

ARHGEF4

166

Q9NR80
QSTLDPSTDSHHTHH

ABCA13

5041

Q86UQ4
DGSRHSGSHHHEASS

FLG

2201

P20930
HHEHSVDSSGHSGSH

FLG

2801

P20930
HEHSVDSSGHSGSHH

FLG

3126

P20930
PLKASHSAHSTHSAH

DHX15

76

O43143
GPAASEHSHRSHHSL

DVL3

626

Q92997
ETHAFTAHPEGKHHS

JAK3

1106

P52333
HSKSHDHFHVDSSTG

FAT1

2326

Q14517
DSEVHSGGSHTHSGH

FLG2

1506

Q5D862
GSHHSEAEGSEKAHS

LEO1

126

Q8WVC0
GSPCHHSDSNSSEKH

DCAF10

366

Q5QP82
HTEKHASGGSTVHIH

HUWE1

3311

Q7Z6Z7
SHHPPAAAHHAESKN

OSBP

521

P22059
HTTHGSESDGHSHGS

CD44

616

P16070
TGSTDSPDHHKHHAS

CCDC85A

216

Q96PX6
SPDHHKHHASSGSPE

CCDC85A

221

Q96PX6
SHSSPHGSHYDSEHV

INO80D

821

Q53TQ3
HMDSSHSHSLSAPHE

CDKL5

576

O76039
SHHHPTTSASHSHGG

SLC31A1

21

O15431
KHSHHSHGPCHSGSD

SLC39A10

646

Q9ULF5
SENGHHSSHKHDREP

CACNA1D

1781

Q01668
HGHHNEQPSSTHDSP

PRR14L

316

Q5THK1
SSASSPPKKEHHHHH

MECP2

356

P51608
VTHSFPSSAHSDTHH

RAB11FIP1

1106

Q6WKZ4
ASDEHTKDSAPSEHH

PRUNE2

1191

Q8WUY3
EHHFHGSKHHSVPIS

NRXN3

56

Q9HDB5
FGSKDSGTLHHPHHH

SENP1

281

Q9P0U3
SHSSGSHHSGSPSAH

SIPA1L2

1341

Q9P2F8
HKDHTHLSPGTATSH

SLC9A5

871

Q14940
KHFPSHHSDSAASSP

CIART

211

Q8N365
PHKSDSGDSFHHSSL

ZNF394

331

Q53GI3
SAHGPEAHATETHCH

SLC16A4

216

O15374
DHTAVHTPAHSWTHS

SPEM3

231

A0A1B0GUW6
THSQAHSPEHTSAHS

SPEM3

316

A0A1B0GUW6
SHHKAHGRSKHPSGS

TMEM94

501

Q12767
HKQCGPSVHPHSSHS

TMEM131

1211

Q92545
KASPSHSDSIHHSSH

PDE4DIP

1636

Q5VU43